Sino Biological has successfully developed anti-payload antibodies which are used for analyzing the plasma/serum PK profiles, DAR values, and drug load distribution of ADC drugs. Anti-payload antibodies are used to evaluate the safety and efficacy of ADC drugs in the preclinical and clinical stages, empowering the ADC drug development process.

As a great partner for pharmaceutical industry, Sino Biological is proud to announce the launch of anti-payload mAbs FREE trial campaign.

Additionally, our product line includes anti-DM1/DM4/SN-38/Dxd mAbs, currently under development, catering to the evolving needs of our clients. Reach out today to get your own trial-size and experience the reliability and quality that Sino Biological brings to the pharmaceutical industry.

Discover More Now!

Contact
Sino Biological Europe GmbH
Düsseldorfer Str. 40, 65760 Eschborn, Germany
+49(0)6196 9678656
order_eu@sinobiologicaleu.com
www.sinobiological.com

Comments to: Anti-payload Antibodies: Facilitating ADC PK studies

Login

Welcome to Life Science News!

"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.